
Commentary|Articles|October 17, 2025
AJMC® in the Press, October 17, 2025
Author(s)Julia Bonavitacola
Fact checked by: Christina Mattina
Listen
0:00 / 0:00
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
An item from
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
From CAR T-Cell Therapy to ADCs: Tackling Oncology Access Gaps
5




